Form 8-K - Current report:
SEC Accession No. 0001564590-19-030043
Filing Date
2019-08-07
Accepted
2019-08-07 16:04:22
Documents
2
Period of Report
2019-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dvax-8k_20190630.htm 8-K 26364
2 EX-99.1 dvax-ex991_6.htm EX-99.1 254618
  Complete submission text file 0001564590-19-030043.txt   282117
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 191005428
SIC: 2834 Pharmaceutical Preparations